49
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27499 |
GSK-A1
|
HCV Protease; PI4K | Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
GSK-A1 是 III 型磷脂酰肌醇 4-激酶 PI4KA 选择性抑制剂,pIC50为 8.5-9.8,抑制 PtdIns(4,5)P2 再合成,IC50约为 3 nM。GSK-A1有效降低 PtdIns(4)P 的水平,而对 PtdIns(4,5)P2 没影响。GSK-A1在抗丙型肝炎病毒方面有研究的潜力。 | |||
T1906 |
Molibresib
GSK 525762A,GSK525762,(4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺,I-BET 762 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
Molibresib (GSK525762) 是一种 BET 溴结构域抑制剂,IC50为32.5在42.5 nM 之间。 | |||
T7361 |
Verucerfont
NBI77860,3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺,GSK561679 |
CRFR | GPCR/G Protein |
Verucerfont (NBI77860) 是促肾上腺皮质激素释放因子受体 1 (CRF1) 拮抗剂,作用于 CRF1(IC50:6.1 nM),CRF2 (IC50>1000 nM)和 CRF-BP (IC50>1000 nM)。 | |||
T9178 |
(E/Z)-GSK-3β inhibitor 1
GSK-3β inhibitor 1 |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
(E/Z)-GSK-3β inhibitor 1 是 (E)-GSK-3β inhibitor 1 和 (Z)-GSK-3β inhibitor 1 的消旋体。它是一种糖原合成酶激酶 3β (GSK-3β)的抑制剂,可其对 GSK-3β 的 IC50=4.9 nM,用于糖尿病的研究。 | |||
T64366 |
GSK3-IN-4
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK3-IN-4是一种 GSK-3抑制剂,对 GSK-3α和 GSK-3β的IC50值为 0.101-1 μM。 | |||
T61809 |
GSK-3β inhibitor 11
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK-3β inhibitor 11(compound 21)是一种强效的糖原合成酶激酶-3β(GSK-3β)抑制剂,其抑制浓度(IC50)为10.02 μM。该化合物在神经退行性疾病研究领域展示了潜在的应用价值[1]。 | |||
T6358 |
1-Azakenpaullone
1-氮杂坎帕罗酮,azakenpaullone |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
1-Azakenpaullone (azakenpaullone) 是一种 ATP 竞争性的、具有高度选择性的糖原合成酶激酶3 β (GSK-3β)的抑制剂,其 IC50=18 nM。 | |||
T6129 |
GSK-1070916
GSK-1070916A,GSK1070916 |
Apoptosis; Tie-2; FLT; AMPK; Aurora Kinase | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
GSK-1070916 (GSK-1070916A) 是一种选择性,ATP 竞争型的极光激酶B/C 抑制剂,Ki 值分别为0.38和1.5 nM。 | |||
T14613 |
BIP-135
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
BIP-135 是一个高效、选择性的,ATP 竞争性的 GSK-3 抑制剂,对 GSK-3α 和 GSK-3β 作用的 IC50 值分别为 16 nM 和 21 nM。BIP 135 具有神经保护作用。 | |||
T2622 |
GSK 650394
GSK650394 |
SGK; Influenza Virus | Metabolism; Microbiology/Virology |
GSK 650394 是一种新颖的 SGK 抑制剂,可抑制流感病毒复制。它还是一种血清和糖皮质激素调节的激酶 1 抑制剂。 | |||
T6003 |
GSK1904529A
GSK 4529 |
Apoptosis; Raf; VEGFR; IGF-1R; Syk | Angiogenesis; Apoptosis; MAPK; Tyrosine Kinase/Adaptors |
GSK1904529A (GSK 4529) 是一种选择性,具有口服活性和 ATP 竞争性的胰岛素样生长因子 1 受体和胰岛素受体抑制剂,IC50值分别为 27 和 25 nM。它具有抗肿瘤活性。 | |||
T61360 |
ARN25068
|
GSK-3; DYRK; Microtubule Associated; Src | Angiogenesis; Cell Cycle/Checkpoint; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
ARN25068是三种蛋白激酶(GSK-3β、FYN和DYRK1A)的亚微摩尔抑制剂,可用于治疗tau相关神经系统疾病。 | |||
T2310L |
CHIR-99021 HCl
CT99021 HCl,Laduviglusib HCl |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
CHIR-99021 HCl (Laduviglusib HCl) 是GSK-3α/β的高效选择性抑制剂,IC50值分别为10 nM和6.7 nM。它对GSK-3表现出显著的选择性,对CDC2、ERK2和其他蛋白激酶的选择性超过500倍。此外,CHIR-99021 HCl 是Wnt/β-catenin信号通路的强大激活剂。此外,它在小鼠和人类胚胎干细胞中都表现出增强自我更新的能力。此外,拉杜维格西单盐酸盐诱导自噬[1][2][3]。 | |||
T16850 |
SB-265610
GSK-CXCR2 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
SB-265610 (GSK-CXCR2) 是竞争性非肽变构CXCR2选择性拮抗剂,可阻断大鼠 CINC-1 诱导的钙动员和中性粒细胞趋化性,IC50分别为 3.7 和 70 nM。 | |||
T6285 |
GSK-690693
GSK690693 |
Serine Protease; Akt; PKC; AMPK; Autophagy | Autophagy; Chromatin/Epigenetic; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
GSK-690693 是一种泛 Akt 抑制剂,对 Akt1、Akt2和 Akt3的 IC50分别为 2 nM、13 nM 和9 nM。它也是一种 AMPK 的抑制剂,影响 ULK1 的活性,并能显著抑制 STING 依赖的 IRF3 的激活。 | |||
T22341 |
GSK-114
|
Others | Others |
GSK 114 是口服有活性的、高选择性的TNNI3K 抑制剂 (IC50= 25 nM)。其中TNNI3K (又称 CARK) 是酪氨酸样激酶家族的成员,选择性在心脏组织中表达。它对 TNNI3K 的选择性是 B-Raf 激酶的 40 倍 (IC50= 1 µM)。 | |||
T6458 |
CYC-116
噻氯匹定 |
VEGFR; FLT; CDK; S6 Kinase; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
CYC116是一种有效的极光激酶 A 和 B 的抑制剂,Ki 值分别为8和9 nM。 | |||
T60485 |
DIF-3
|
||
DIF-3 is a chemical compound that acts by activating GSK-3β to facilitate the degradation of cyclin D1 and c-Myc, resulting in reduced expression levels of these proteins. In addition, DIF-3 inhibits Wnt/β-catenin signaling pathway-related proteins in DLD-1 cells. This compound exerts a potent antiproliferative effect on the HeLa human cervical cancer cell line by inducing cyclin D1 degradation and inhibiting cyclin D1 mRNA expression [1]. | |||
T2378 |
RGB-286638 free base
|
GSK-3; MEK; JAK; CDK | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; PI3K/Akt/mTOR signaling; Stem Cells |
RGB-286638 free base 是一种新型 CDK 抑制剂,抑制cyclin T1-CDK9、cyclin B1-CDK1、cyclin E-CDK2、cyclin D1-CDK4、cyclin E-CDK3和p35-CDK5活性,IC50分别为 1、2、3、4、5 和 5 nM。它也抑制 GSK-3β、TAK1、Jak2 和 MEK1,IC50值分别为 3、5、50和 54 nM。 | |||
T11468 | GSK-3 inhibitor 1 | GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK-3 inhibitor 1 is a GSK-3 inhibitor. | |||
T22157 |
TCS 2002
|
||
GSK-3β inhibitor 9 (Compound 9b) 是一种具有高选择性、口服有效的 GSK-3β抑制剂,IC50为 35 nM。GSK-3β inhibitor 9 显示出良好的药代动力学特征,包括良好的血脑屏障渗透。GSK-3β inhibitor 9 可用于阿尔茨海默病的研究。 | |||
T64143 |
AChE/GSK-3β-IN-1
|
||
AChE/GSK-3β-IN-1 是一种有效的、能透过血脑屏障的双重AChE/GSK-3β抑制剂,能够作用于 hAChE (IC50: 1.2 nM)、hBChE (IC50: 149.8 nM) 和 hGSK-3β (IC50: 22.4 nM)。AChE/GSK-3β-IN-1 能够占据 DYRK1A 的 ATP 结合位点。AChE/GSK-3β-IN-1 对 CMGC 激酶家族表现出较高的激酶选择性。AChE/GSK-3β-IN-1 能够抑制 ROS 表达,减少氧化应激。AChE/GSK-3β-IN-1 能够用于研究阿尔兹海默症。 | |||
T27488 |
GSK-690
GSK 690 |
||
GSK-690 is a potent, reversible and selective inhibitors of Lysine Specific Demethylase 1. | |||
T70965 | GSK-2245035 maleate | ||
GSK-2245035 maleate is a selective Toll-like receptor 7 (TLR7) agonist with preferential Type-1 interferon (IFN)-stimulating properties. | |||
T61804 | GSK-3β inhibitor 6 | ||
GSK-3β inhibitor 6 is a highly potent inhibitor of GSK-3β, with an IC50 value of 24.4 μM. It demonstrates significant enhancement of hepatocyte glucose uptake (38%). This compound holds great potential for studying various diseases including diabetes, inflammation, cancer, Alzheimer's disease, and bipolar disorder [1]. | |||
T27442 |
GSK 224876
GSK-224876,GSK224876 |
||
GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects. | |||
T11473 | GSK-5498A | Others | Others |
GSK-5498A is a selective blocker of CARC (IC50, 1 μM). It inhibits mediator release from mast cells, and pro-inflammatory cytokine release from T-cells in a variety of species. | |||
T76088 |
GSK3 Substrate, α, β subunit
|
||
GSK3 Substrate, α, β subunit 是糖原合酶激酶-3 (GSK-3) 的肽底物,可用于测量GSK-3活性。 | |||
T24969 |
18BIOder
18 BIOder,18-BIOder |
||
18BIOder is a neuroprotective inhibitor of GSK-3β, highly selectively inhibiting HIV-1. It is the second generation derivative of 6BIO. | |||
T70724 |
GSK-2256098 HCl
|
||
GSK-2256098 HCl is a focal adhesion kinase-1 (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. | |||
T11503 |
GSK 690 Hydrochloride
|
Histone Demethylase | Chromatin/Epigenetic |
GSK 690 (Hydrochloride) 是一种可逆的赖氨酸特异性去甲基化酶1 (LSD1)抑制剂,Kd 值为 9 nM,IC50值为 37 nM。 | |||
T27445 |
GSK-1004723
GSK 1004723 |
||
GSK-1004723 is a novel antagonist of histamine H(1) and H(3) receptor. It represents a potential novel therapy for allergic rhinitis. | |||
T41232 |
GSK 2833503A
|
||
GSK 2833503A is a potent and selective TRPC6 and TRPC3 antagonist (IC50 = 3-16 nM and 21-100 nM, respectively). GSK 2833503A exhibits >63-fold selectivity over other ion channels, including other TRP channels, CaV1.2, hERG and NaV1.5. GSK 2833503A suppresses angiotensin II or endothelin-1-induced cardiac hypertrophy signaling in HEK293 cellsin vitroand in cardiomyocytes. | |||
T27446 |
GSK-1034702
GSK-1034702 HCl,GSK 1034702 |
||
GSK-1034702 is a selective M(1) receptor allosteric agonist, it may have therapeutic benefits in disorders of impaired learning including Alzheimer's disease. | |||
T68855 |
Hymenialdisine Analogue #1
|
||
Hymenialdisine Analogue #1 is the indole derivative of Hymenialdisine, a potent inhibitor of a variety of kinases including MEK-1, GSK-3Β, and CKI. It also exhibits inhibition of the G2 cell cycle checkpoint at the micromolar concentrations. | |||
T27461 |
GSK2336805
GSK 2336805,GSK-2336805,JNJ-56914845,GSK-805,GSK805 |
||
GSK-2336805 is a HCV NS5A inhibitor. GSK2336805 retained activity on chimeric replicons containing NS5A patient sequences from genotype 1 and patient and consensus sequences for genotypes 4 and 5 and part of genotype 6. | |||
T11466 |
GSK-2793660
|
Others | Others |
GSK-2793660 是一种具有口服活性并且不可逆的组织蛋白酶 C (Cathepsin C;CTSC) 抑制剂。GSK-2793660 是一种生物活性肽,可用于支气管扩张的研究。 | |||
T77156 | Depemokimab | ||
Depemokimab (GSK-3511294) 是一种长效的抗IL-15单克隆抗体。Depemokimab 可用于哮喘研究。 | |||
T69986 |
BMS-955176 HCl
|
||
GSK-3532795 is a second generation inhibitor of hiv-1 maturation, exhibiting a broader spectrum of antiviral effect in vitro and in clinical studies than the prototypical maturation inhibitor bevirimat | |||
T80124 |
C-Peptide 1 (rat)
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
C-Peptide 1 (rat) 为肽类化合物,作为β-catenin/GSK-3β激活剂,具有调节Wnt/β-catenin信号通路的功能,常用于癌症研究领域。 | |||
T60748 |
ZDWX-25
|
||
ZDWX-25 是 GSK-3β和 DYRK1A 的高效双重抑制剂,它对 SH-SY5Y 和 HL-7702 细胞显示出显著的细胞毒性。ZDWX-25 可用于研究阿尔茨海默症,其对 GSK-3β 的 IC50值为 71 nM。。 | |||
T11960 |
MBM-55
|
GSK-3; MAPK; DYRK; Akt; Chk; Bcr-Abl; CDK; S6 Kinase; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
MBM-55 是一种有效的中心体相关激酶 2 (NEK2) 抑制剂,IC50 为 1 nM。 MBM-55 通过诱导细胞周期停滞和凋亡有效抑制癌细胞的增殖。 | |||
T11961 |
MBM-55S
|
GSK-3; MAPK; Akt; Bcr-Abl; CDK; S6 Kinase; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
MBM-55S 是一种有效的 Nek2 抑制剂,IC50 为 1 nM。 MBM-55S 抑制细胞周期停滞和凋亡,从而抑制癌细胞的增殖。 MBM-55S 表现出抗肿瘤作用。 | |||
T81692 |
Nelistotug
|
||
Nelistotug (GSK 6097608; GSK6097608) 是一种针对CD96的人源化IgG1κ抗体。CD96属于免疫球蛋白超家族,被认为是潜在的免疫检查点靶标。 | |||
T75808 |
Phospho-Glycogen Synthase Peptide-2(substrate) TFA
|
||
Phospho-Glycogen Synthase Peptide-2 (底物)为糖原合酶激酶-3 (GSK-3) 的特异性肽底物,适用于蛋白丝氨酸激酶的亲和纯化。 | |||
T79693 | PIMPC | GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
PIMPC为具抗氧化及金属螯合性能之化合物,新型糖原合成酶激酶3(GSK-3)抑制剂,潜在抗阿尔茨海默病作用。 | |||
T80587 |
Alunacedase alfa
HrsACE2,GSK 2586881 |
SARS-CoV | Microbiology/Virology |
Alunacedase alfa (HrsACE2; GSK 2586881) 是一种人源重组的可溶性血管紧张素转化酶 2(hrsACE2)。作为转基因可溶性形态的 ACE2,Alunacedase alfa 能够减少 SARS-CoV-2 与细胞膜结合 ACE2 的竞争性进入,因此具有研究 SARS-CoV-2 的可能性。 | |||
T35560 |
SAR502250
|
||
SAR502250 is a potent, selective, ATP competitive, orally active and brain-penetrant inhibitor of GSK3, with an IC50 of 12 nM for human GSK-3β. SAR502250 displays antidepressant-like activity. SAR502250 can be used for the research of Alzheimer’s disease (AD)[1][2]. SAR502250 (0.01-1 μM; 36 h) attenuates the Aβ25-35-induced cell death in rat embryonic hippocampal neurons[2]. SAR502250 (1-100 mg/kg; a single p.o,) attenuates tau hyperphosphorylation in the cortex and spinal cord of transgenic mic... | |||
T73196 |
RGB-286638
|
||
RGB-286638 是一种有效的 CDK 抑制剂,抑制cyclin T1-CDK9,cyclin B1-CDK1,cyclin E-CDK2,cyclin D1-CDK4,cyclin E-CDK3和p35-CDK5活性,IC50分别为 1,2,3,4,5 和 5 nM;同时可抑制GSK-3β,TAK1,Jak2和MEK1,IC50值分别为 3,5,50,和 54 nM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6S0653 |
Linarin
Buddleoflavonoloside,Buddleoside,Acacetin-7-O-rutinoside,Acaciin,Linarine,蒙花苷 |
TNF; AChE | Apoptosis; Neuroscience |
Linarin (Acacetin-7-O-rutinoside) 是一种选择性的乙酰胆碱酯酶 (AChE) 抑制剂,从薄荷花提取物中分离得到。 | |||
TN5171 |
Tricetin
|
Apoptosis; Others; Nrf2 | Apoptosis; Immunology/Inflammation; Others |
Tricetin 是一种从石榴中分离出的类黄酮。Tricetin 是 Keap1-Nrf2 蛋白相互作用(PPI)的强效竞争性抑制剂,通过激活 Nrf2/HO-1 信号通路和阻止线粒体依赖性细胞凋亡通路,保护帕金森病患免受 6-OHDA 诱导的神经毒性的影响。Tricetin 通过 Akt/GSK-1β途径抑制鼻咽癌的迁移和指示性蛋白酶早老素-1(PS-1)表达。Tricetin 抑制由Egr-1介导的氧化LDL 诱导的内皮炎症,保护大鼠软骨细胞免受IL-1β诱导的炎症和细胞凋亡。 | |||
T38441 |
Manzamine A hydrochloride
|
||
Manzamine A hydrochloride is an orally active beta-carboline alkaloid that exhibits specific inhibitory effects on GSK-3β (IC50 = 10.2 μM) and CDK-5 (IC50 = 1.5 μM). Additionally, it targets vacuolar ATPases, leading to the inhibition of autophagy in pancreatic cancer cells. Manzamine A hydrochloride possesses antimalarial and anticancer properties, and also demonstrates potent activity against HSV-1[4]. |